Your search for "antibiotics" return 31 results.
Research and innovation in animal health: a strengthened partnership between INRAE and Ceva Santé Animale >
A shared commitment to the "One Health" global health concept
Ceva builds on its preventative health strategy with opening of a new European reference for the manufacture of autogenous vaccines >
An innovative project confirms Ceva’s commitment to improving preventative animal health and reducing the use of antibiotics.
Ceva partners with Biotecon Diagnostics to introduce a real-time test kit to fight growing problem of salmonella on pig farms >
Libourne 10th September 2019 - A new real-time diagnostic kit that will help pig producers fight salmonella infections on their farms has been launched at the SafePork scientific symposium in Berlin.
Laval, 25 June 2019 - Ceva, France’s largest veterinary biopharmaceutical company, has consolidated its investments in Mainland France, specifically in Laval, where it has established its global hub f...
Ceva Santé Animale and IDT Biologika GmbH announce agreement for Ceva to acquire the IDT animal health business, expanding its global vaccine portf... >
Libourne & Dessau 17th. May 2019 - Ceva Santé Animale (“Ceva”) and IDT Biologika GmbH (“IDT”) have reached a provisional agreement for Ceva to acquire IDT’s veterinary biopharmaceutical portfolio and...
4 April 2019 The winners of the prestigious Ceva Animal Welfare Awards 2019 have been announced in a glittering ceremony in The Mercian Suite at the Birmingham Conference & Events Centre in Birmingham...
IPPE 2019 – Ceva’s latest innovations offer producers greater performance optimisation from the hatchery >
7th February 2019, Altanta, USA - In 2019, Ceva will introduce several notable additions to its Vaccinology range of products, equipment and services drawing from the 9 Innovation Areas introduced in...
Ceva launches a “new wave of innovation” to help poultry producers meet the performance challenges driven by the need for “No antibiotics” and more sustainable production
Ceva’s teams brought innovation to the fore during VIV Asia 2017
Move will reinforce group’s AMR strategy to find alternative solutions to use of antibiotics